These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 2670219)

  • 1. ACE inhibitors in hypertension: a European viewpoint.
    Zannad F; Gilgenkrantz JM
    Cardiology; 1989; 76 Suppl 2():31-41. PubMed ID: 2670219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin-converting enzyme inhibitors in the treatment of hypertension.
    Mancia G
    J Cardiovasc Pharmacol; 1991; 18 Suppl 7():S1-3. PubMed ID: 1725194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ACE inhibitors as initial therapy for hypertension.
    Schoenberger JA
    Am Fam Physician; 1988 Apr; 37(4):139-46. PubMed ID: 3282415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination ACE inhibitors and angiotensin II receptor blockers for hypertension.
    Finnegan PM; Gleason BL
    Ann Pharmacother; 2003 Jun; 37(6):886-9. PubMed ID: 12773079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The safety of ACE inhibitors for the treatment of hypertension and congestive heart failure.
    Frank GJ
    Cardiology; 1989; 76 Suppl 2():56-67. PubMed ID: 2670222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in hypertension due to primary aldosteronism: a case for exclusion.
    Bubbar CD; Blackburn DF; Wilson MP; Wilson TW
    Ann Pharmacother; 2007 Jan; 41(1):129-32. PubMed ID: 17179189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trandolapril: an ACE inhibitor for treatment of hypertension.
    Med Lett Drugs Ther; 1996 Nov; 38(988):104-5. PubMed ID: 8941256
    [No Abstract]   [Full Text] [Related]  

  • 8. The expanding role of angiotensin converting enzyme inhibitors in the management of hypertension.
    Burris JF
    J Clin Pharmacol; 1995 Apr; 35(4):337-42. PubMed ID: 7650220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin converting enzyme (ACE) inhibitors in hypertensive aircrew.
    Amroliwalla FK
    Aviat Space Environ Med; 1994 Nov; 65(11):1054-7. PubMed ID: 7840747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The renin-angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril in clinical trials versus routine practice: insights from the prospective EARLY registry.
    Bramlage P; Schmieder RE; Gitt AK; Baumgart P; Mahfoud F; Buhck H; Ouarrak T; Ehmen M; Potthoff SA;
    Trials; 2015 Dec; 16():581. PubMed ID: 26686682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease. The Task Force on ACE-inhibitors of the European Society of Cardiology.
    López-Sendón J; Swedberg K; McMurray J; Tamargo J; Maggioni AP; Dargie H; Tendera M; Waagstein F; Kjekshus J; Lechat P; Torp-Pedersen C;
    Eur Heart J; 2004 Aug; 25(16):1454-70. PubMed ID: 15302105
    [No Abstract]   [Full Text] [Related]  

  • 12. The impact of ACE inhibition on all-cause and cardiovascular mortality in contemporary hypertension trials: a review.
    Ferrari R; Boersma E
    Expert Rev Cardiovasc Ther; 2013 Jun; 11(6):705-17. PubMed ID: 23750680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertension monotherapy with ACE inhibitors.
    Yeolekar ME
    J Assoc Physicians India; 1992 Feb; 40(2):79-81. PubMed ID: 1629138
    [No Abstract]   [Full Text] [Related]  

  • 14. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
    Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D
    Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The value of angiotensin-converting enzyme inhibitors in the treatment of hypertension].
    Klaus D
    Z Kardiol; 1988; 77 Suppl 3():73-88. PubMed ID: 3062960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-converting enzyme inhibitors in hypertension. A dozen years of experience.
    Materson BJ; Preston RA
    Arch Intern Med; 1994 Mar; 154(5):513-23. PubMed ID: 8122944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [ACE inhibitors for protection against hypertensive target-organ damage].
    Kihara M; Hashimoto T; Umemura S
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():564-8. PubMed ID: 15171436
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-range safety and protective benefits of angiotensin-converting enzyme inhibitors for hypertension. Do we need more clinical trials?
    Sambhi MP; Gavras H; Robertson JI; Smith WM
    West J Med; 1993 Mar; 158(3):286-94. PubMed ID: 8460511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapy of hypertension with ACE inhibitors. One third fewer cases of diabetes].
    MMW Fortschr Med; 2002 Mar; 144(10):63. PubMed ID: 11928273
    [No Abstract]   [Full Text] [Related]  

  • 20. [Captopril and other angiotensin converting enzyme inhibitors in the treatment of hypertension].
    Hradec J
    Vnitr Lek; 1995 May; 41(5):336-9. PubMed ID: 7653065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.